Ballistocardiography is a non-invasive, time- and cost-efficient technology with potential clinical and applied research applications for measuring cardiac cycle events.
BCG may enable accessible cardiac monitoring; leaves open its clinical utility pending prospective validation studies.
Ballistocardiography (BCG) is a non-invasive technology that has been used to record ultra-low-frequency vibrations of the heart allowing for the measurement of cardiac cycle events including timing and amplitudes of contraction. Recent developments in BCG have made this technology simple to use, as well as time- and cost-efficient in comparison with other more complicated and invasive techniques used to evaluate cardiac performance. Recent technological advances are considerably greater since the advent of microprocessors and laptop computers. Along with the history of BCG, this paper reviews the present and future potential benefits of using BCG to measure cardiac cycle events and its application to clinical and applied research.
No takes yet. Share an insight, caveat, or question.
Vogt et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: